← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

A

$ Value

$9.0M

Shares

440,000

Price

$20

Filed

Feb 6

Insider

Name

Metzger Michael A

Title

Chief Executive Officer

CIK

0001507220

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-04

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

440,000

Footnotes

Award of restricted stock units ("RSUs"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested. | Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company. | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. | 1/48th of the shares subject to the option shall vest monthly over a four-year period.

Filing Info

Accession No.

0001193125-26-041500

Form Type

4

Issuer CIK

0001395937

Metzger Michael A's History

Date Ticker Type Value
2026-03-24 PYXS A $0
2026-02-09 SNDX $361K
2026-02-06 SNDX $153K
2026-02-04 SNDX A $0
2026-02-04 SNDX A $0
2026-02-04 SNDX A $9.0M
2025-09-08 SNDX M $1.7M
2025-09-08 SNDX $2.6M
2025-09-08 SNDX M $0
2025-07-16 SNDX $70K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04